Nodular regenerative hyperplasia: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
Revision as of 20:09, 4 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nodular regenerative hyperplasia is a form of liver hyperplasia associated with portal hypertension.[1]
It can be a complication of azathioprine therapy.[2][3]
References
- ↑ Shelly D, Tevatia MS, Praharaj AK, Mehta A, Harish S, Baskaran V (2008). "Nodular regenerative hyperplasia of liver". Indian J Pathol Microbiol. 51 (1): 78–80. PMID 18417867.
- ↑ Daniel F, Cadranel JF, Seksik P; et al. (2005). "Azathioprine induced nodular regenerative hyperplasia in IBD patients". Gastroenterol. Clin. Biol. 29 (5): 600–3. PMID 15980758. Unknown parameter
|month=ignored (help) - ↑ Vernier-Massouille G, Cosnes J, Lemann M; et al. (2007). "Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine". Gut. 56 (10): 1404–9. doi:10.1136/gut.2006.114363. PMID 17504943. Unknown parameter
|month=ignored (help)